Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01629095 · ClinicalTrials.gov registry record
Genetic Studies of Non-Alcoholic Fatty Liver Disease
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Terminated
- Registry status
- 17
- Enrollment target
NCT01629095 is a clinical trial that was terminated before completion, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 17 participants.
The verdict
NCT01629095 was terminated before completion, sponsored by National Human Genome Research Institute (NHGRI).
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Background: \- Non-alcoholic fatty liver disease is the most common form of liver disease in the United States. It includes many conditions. Researchers want to study fatty liver disease by looking at people who have liver cirrhosis. They also want to look at people who are or were listed for liver transplants. Genetic studies may provide more information on the causes of these conditions. Objectives: \- To study possible genetic causes of non-alcoholic fatty liver disease. Eligibility: \- Individuals of any age who have non-alcoholic fatty liver disease and related conditions. Design: * Participants will be screened with a physical exam and medical history. * Participants will provide a blood sample for genetic testing. Liver tissue from a transplant or biopsy may also be studied. * Participants may also be asked to have an imaging study of the liver. This imaging study may be an x-ray or magnetic resonance imaging. * No treatment will be provided as part of this research study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-04-23 |
| Est. Completion | 2017-01-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01629095
The ClinicalTrials.gov registry entry for NCT01629095 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01629095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01629095 about?
NCT01629095 is a clinical study titled "Genetic Studies of Non-Alcoholic Fatty Liver Disease". Background: \- Non-alcoholic fatty liver disease is the most common form of liver disease in the United States. It includes many conditions. Researchers want to study fatty liver disease by looking at people who have liver cirrhosis. They also want to look at people who are or were listed for liver...
What is the current status of trial NCT01629095?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2013-04-23. Estimated completion is 2017-01-09.
Who is sponsoring clinical trial NCT01629095?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.